Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pierre Lapalme Insider Profile
4 Followers
Pierre Lapalme, Director at BioMarin Pharmaceutical, holds 19.08K shares in Insys Therapeutics (Ticker: INSYQ), holds 32.75K shares in BioMarin Pharmaceutical (Ticker: BMRN).
Pierre Lapalme has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Pierre Lapalme holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 05, 2015 - Mar 05, 2016
Return:+23.60%
The most profitable trade made by Pierre Lapalme
Pierre Lapalme's Trading History
BioMarin Pharmaceutical
Jun 18, 2015
Director
Uninformative Buy
―
$2.77M
Insys Therapeutics
Apr 23, 2019
―
Uninformative Buy
―
$801.49
List of latest transactions for each holding click on a transaction to see Pierre Lapalme's performance on stock
You May Also Like
Pierre Lapalme insider profile FAQ
What is the percentage of profitable transactions made by Pierre Lapalme?
The percentage of profitable transactions made by Pierre Lapalme is ―.
What is the average return per transaction made by Pierre Lapalme?
The average return per transaction made by Pierre Lapalme is ―.
What stocks does Pierre Lapalme hold?
Pierre Lapalme holds: BMRN, INSYQ stocks.
What was Pierre Lapalme’s latest transaction?
Pierre Lapalme latest transaction was an Uninformative Buy of ―.
What was Pierre Lapalme's most profitable transaction?
Pierre Lapalme’s most profitable transaction was an Informative Sell of BMRN stock on March 5, 2015. The return on the trade was 23.60%.
What is Pierre Lapalme's role in BioMarin Pharmaceutical?
Pierre Lapalme's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.